Use your antibodies-online credentials, if available.
抗Mouse (Murine) POR 抗体:
抗Rat (Rattus) POR 抗体:
抗Human POR 抗体:
Arabidopsis thaliana Polyclonal POR Primary Antibody for WB - ABIN2688654
Wei, Zhou, Hu, Wei, Yang, Huang: Heterotrimeric G-protein is involved in phytochrome A-mediated cell death of Arabidopsis hypocotyls. in Cell research 2008
Show all 6 Pubmed References
Arabidopsis thaliana Polyclonal POR Primary Antibody for WB - ABIN349645
Wei, Zhou, Hu, Wei, Yang, Huang: Heterotrimeric G-protein is involved in phytochrome A-mediated cell death of Arabidopsis hypocotyls. in Cell research 2009
Show all 5 Pubmed References
Human Polyclonal POR Primary Antibody for IF, WB - ABIN950123
Araki, Tsuruoka, Hasegawa, Yanagihara, Omasa, Enosawa, Yamazoe, Fujimura: Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells. in The Journal of pharmacy and pharmacology 2012
Cow (Bovine) Polyclonal POR Primary Antibody for IHC, WB - ABIN2773843
Lee, Kim, Yoon, Lee: Cytochrome P450 system expression and DNA adduct formation in the liver of Zacco platypus following waterborne benzo(a)pyrene exposure: implications for biomarker determination. in Environmental toxicology 2014
we observed that miR (显示 MLXIP 抗体)-378 modulates the oscillation amplitudes of Cdkn1a (显示 CDKN1A 抗体) in the control of cell cycle and Por in the regulation of oxidation reduction by forming partnership with different circadian transcription factors
Highest level of Rac1 activation was achieved on the smallest nanofibers, a trend that was lost in POR1 knockdown. This supports the hypothesis that on small nanofibers, POR1 binds to highly curved cell membranes, allowing Rac1 to dissociate and activate.
Results are the first to show that some forms of opioid-mediated stress-induced analgesia require brain neuronal P450 activity.
Immunological and metabolic changes resulting from a genetic deficiency in CPR (显示 GRID2 抗体) expression in the intestine in mice.
An apparent link exists between the cytochrome p450 reductase and FGF signaling pathways.
These data collectively indicate a novel role of the Cpr (显示 GRID2 抗体) gene in fear conditioning and memory.
this study provides novel insights into the regulation of gap junction function by CYPOR and suggests that Cx43 (显示 GJA1 抗体) may play an important role(s) in CYPOR-mediated bone defects seen in patients.
inactivation of the hepatic cytochrome P450 (显示 CYP 抗体) system by conditional deletion of this enzyme
Changes in hepatic mRNA expression using microarray analysis and real-time PCR in POR null mice are reported.
POR function is indispensable for the proper regulation of retinoic acid levels and tissue distribution not only during early embryonic development but also in later morphogenesis and molecular patterning of the brain, abdominal/caudal (显示 CAD 抗体) region and limbs.
NADPH-P450 reductase (NPR) was purified from hepatic microsomes of Xenopus laevis.
A homodimer model can resolve the conundrum as to how cytochrome P450 (显示 CYP 抗体) oxidoreductase (显示 TXNRD1 抗体) and cytochrome b5 (显示 CYB5A 抗体) compete for the same binding site on cytochrome P450c17 (显示 CYP17A1 抗体). (Review)
Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-bixler syndrome phenotype in three sibling fetuses
To promote intracellular iron flux, an iron chaperone appears to be essential for receiving iron from heme catabolism. Data suggest that PCBP2 (显示 PCBP2 抗体) competes with CPR for binding HO1 (显示 HMOX1 抗体); PCBP2 (显示 PCBP2 抗体) K homology 3 domain is important for HO1 (显示 HMOX1 抗体)/PCBP2 (显示 PCBP2 抗体) interaction; heme prompts HO1 (显示 HMOX1 抗体)/CPR multimer and decreases HO1 (显示 HMOX1 抗体)/PCBP2 (显示 PCBP2 抗体) multimer. [PCBP2 (显示 PCBP2 抗体) = poly(rC) binding protein 2 (显示 PCBP2 抗体); CPR = cytochrome P450 reductase; HO1 (显示 HMOX1 抗体) = heme oxidase 1]
analysis of mutations and polymorphisms in POR linked to metabolism of steroids and xenobiotics and pathology of P450 (显示 CYP2B6 抗体) oxidoreductase (显示 TXNRD1 抗体) deficiency (PORD)
No significant differences in the distribution of haplotypes between cases and controls were detected. In conclusion, this study reveals that four SNPs in the POR gene (rs3823884, rs3898649, rs239953 and rs17685) may affect the susceptibility of smoking cessation in a Chinese Han population.
analysis of the role of the active site loop in coenzyme binding and flavin reduction in cytochrome P450 reductase
Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.
population pharmacokinetic analysis identified that the combined genotype of CYP3A5 (显示 CYP3A5 抗体)-POR was the only covariant for the apparent clearance of tacrolimus
Case Report: delayed diagnosis of 46, XY disorder of sex development due to P450 (显示 CYP2B6 抗体) oxidoreductase (显示 TXNRD1 抗体) (POR) deficiency.
Interindividual variability in CYP2C19 (显示 CYP2C19 抗体) activity is due to differences in both CYP2C19 (显示 CYP2C19 抗体) protein content associated with gene diplotypes and the cytochrome P450 (显示 CYP 抗体) oxidoreductase (显示 TXNRD1 抗体) content.
Data indicate not only that binding of b5 and P450 reductase on the proximal surface of P450 2B4 (显示 CD244 抗体) results in electron transfer but also that each redox partner transmits unique structural information to the active site proton delivery network.
This gene encodes an endoplasmic reticulum membrane oxidoreductase with an FAD-binding domain and a flavodoxin-like domain. The protein binds two cofactors, FAD and FMN, which allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene have been associated with various diseases, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome.
, NADPH-cytochrome P450 oxidoreductase
, P450 reductase
, cytochrome P450 reductase
, cytochrome c reductase (NADPH)
, P450 (cytochrome) oxidoreductase
, NADPH--cytochrome P450 reductase-like
, ADP-ribosylation factor-interacting protein 2
, Arfaptin 2
, partner of RAC1
, ADP-ribosylation factor interacting protein 2 (arfaptin 2)
, partner of Rac1
, NADPH--cytochrome P450 reductase
, NADPH-P450 reductase
, NADPH-dependent cytochrome P450 reductase
, NADPH-cytochrome P450 reductase
, NADPH-cytochrome P-450 oxidoreductase
, NADH cytochrome P450 oxydoreductase